Related Experiment Video
Updated: Jul 23, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via
Alfonso Parreño Torres1, Carlos Roncero-Parra2, Alejandro L Borja1
1School of Industrial Engineering, University of Castilla-La Mancha, Albacete, Spain.
Electroencephalography (EEG) with machine learning (ML) accurately identifies Alzheimer's disease (AD) stages. Random Forest achieved over 93% accuracy in classifying advanced AD and mild-to-moderate AD (ADM) patients, showing promise for diagnostic tools.
Area of Science:
- Neuroscience
- Computational Biology
- Medical Diagnostics
Background:
- Alzheimer's disease (AD) diagnosis requires tools to differentiate disease stages.
- Electroencephalography (EEG) and machine learning (ML) offer a potential non-invasive approach.
Purpose of the Study:
- To evaluate the efficacy of six classical ML algorithms in classifying AD stages.
- To assess the diagnostic accuracy of EEG-ML for mild-to-moderate AD (ADM) and advanced AD (ADA).
Main Methods:
- Utilized a dataset of 668 patients from multiple hospitals (2011-2022).
- Classified patients into control, ADM, and ADA groups.
- Employed six ML algorithms: SVM, BLDA, Decision Tree, GNB, KNN, and Random Forest (RF).
Main Results:
- The Random Forest (RF) algorithm demonstrated superior performance.
- RF achieved 93.55% balanced accuracy for ADA classification.
- RF achieved 93.25% balanced accuracy for ADM classification.
Conclusions:
- EEG combined with ML provides a robust method for AD classification.
- The study highlights the feasibility of using straightforward ML models for reliable AD diagnosis.
- This approach shows significant potential for developing advanced diagnostic tools for Alzheimer's disease.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Dementia l: Introduction

